Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Luiz Madaleno Franco"'
Autor:
Miriéle Cristina Ferraz, Eliana Aparecida Varanda, Edson Hideaki Yoshida, Pilar Puebla, Márcio Galdino dos Santos, Cháriston André Dal-Belo, Yoko Oshima-Franco, Renata V. da Silva Tavares, Rone Aparecido De Grandis, Luiz Madaleno Franco, José Carlos Cogo, Natália Tribuiani, Francisco Carlos Groppo, Flávia Aparecida Resende, Arturo San-Feliciano
Publikováno v:
Chinese Medicine. :1-12
Phenolic compounds from Dipteryx alata Vogel were assayed against the in vitro neurotoxic effect induced by Bothrops jararacussu (Bjssu) venom. Mutagenicity was assessed by the Ames test using Salmonella typhimurium strains TA98, TA97a, TA100, and TA
Autor:
Jorge Amaral Filho, Luiz Madaleno Franco, Márcio Galdino dos Santos, Maria Silvia Duarte Moraes, Francisco Carlos Groppo, Pilar Puebla, Luciane Aparecida Celestino Parrilha, Yoko Oshima-Franco, José Carlos Cogo, Miriéle Cristina Ferraz, Arturo San Feliciano
Publikováno v:
Web of Science
Autor:
Márcio Galdino dos Santos, Yoko Oshima-Franco, Arturo San Feliciano, Luiz Madaleno Franco, Leandro Rubem-Mauro, Renata V. da Silva, Pilar Puebla
Publikováno v:
Molecules; Volume 15; Issue 11; Pages: 8193-8204
Molecules
Molecules, Vol 15, Iss 11, Pp 8193-8204 (2010)
Molecules
Molecules, Vol 15, Iss 11, Pp 8193-8204 (2010)
The effect of four sub-extracts prepared from the lyophilized hydroalcoholic bark of Dipteryx alata (Leguminosae-Papilionoideae) dissolved in a methanol-water (80:20) mixture through a liquid-liquid partition procedure has been investigated against t
Autor:
Márcio Galdino dos Santos, Helena Onishi Ferraz, Marisa Maria Teixeira da Rocha, Pilar Puebla, Stephen Hyslop, Humberto Gomes Ferraz, Luiz Madaleno Franco, Miriéle Cristina Ferraz, Joel Reis de Oliveira Junior, Yoko Oshima-Franco, José Carlos Cogo, Jhones Luiz de Oliveira, Arturo San Feliciano
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
GREDOS: Repositorio Institucional de la Universidad de Salamanca
Universidad de Salamanca (USAL)
GREDOS. Repositorio Institucional de la Universidad de Salamanca
instname
Evidence-Based Complementary and Alternative Medicine, Vol 2015 (2015)
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
GREDOS: Repositorio Institucional de la Universidad de Salamanca
Universidad de Salamanca (USAL)
GREDOS. Repositorio Institucional de la Universidad de Salamanca
instname
Evidence-Based Complementary and Alternative Medicine, Vol 2015 (2015)
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
We confirmed the ability of the triterpenoid betulin to protect against neurotoxicity caused byBothrops jararacussusnake venomin vitroin mouse isolated phrenic nerve-diaphragm (PND) preparations and examined its capability ofin vivoprotection using t
Autor:
Ana Paula Del Bortolo Ruenis, Gilson Cesar Nobre Franco, Luiz Madaleno Franco, Priscilla Guimarães Silva, Pedro Luiz Rosalen, Francisco Carlos Groppo, R C C Baglie, S Baglie
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 43:350-354
Objective: To compare the bioavailability of amoxicillin 875 mg tablets (EMS Sigma Pharma used as test formulation) and Amoxil® BD 875 mg tablets (GlaxoSmithKline used as reference formulation) in 26 healthy volunteers. Material and methods: 26 heal
Autor:
Pedro Luiz Rosalen, Sinvaldo Baglie, Yoko Oshima-Franco, Luiz Madaleno Franco, Karina Cogo, Francisco Carlos Groppo, Ana Paula Del Bortolo Ruenis, Gilson Cesar Nobre Franco, Paulo Silva
Publikováno v:
International journal of clinical pharmacology and therapeutics. 52(5)
Purpose To compare the pharmacokinetic profiles and to evaluate the bioequivalence of two commercial amoxicillin suspension formulations (500 mg/5 mL AMOXIL®, reference formulation and AMOXI-PED®, test formulation) in healthy Brazilian volunteers.
Autor:
Miriéle Cristina Ferraz, Flávia Aparecida Resende, José Carlos Cogo, Arturo San Feliciano, Stephen Hyslop, Adélia Cristina Oliveira Cintra, Luiz Madaleno Franco, Yoko Oshima-Franco, Edson Hideaki Yoshida, Renata V. da Silva Tavares, Márcio Galdino dos Santos, Cháriston André Dal Belo, Eliana Aparecida Varanda, Pilar Puebla
Publikováno v:
Molecules
Molecules, Vol 19, Iss 5, Pp 5790-5805 (2014)
Molecules; Volume 19; Issue 5; Pages: 5790-5805
Web of Science
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Molecules, Vol 19, Iss 5, Pp 5790-5805 (2014)
Molecules; Volume 19; Issue 5; Pages: 5790-5805
Web of Science
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Made available in DSpace on 2014-12-03T13:09:12Z (GMT). No. of bitstreams: 0 Previous issue date: 2014-05-01Bitstream added on 2014-12-03T13:23:14Z : No. of bitstreams: 1 WOS000337113000022.pdf: 777492 bytes, checksum: 4a0d3e39a47c66366e3daa864fc5a96
Autor:
E. Abib-Junior, R. A. Moreno, R. P. Simoes, Pedro Luiz Rosalen, Sinvaldo Baglie, Luiz Madaleno Franco, Francisco Carlos Groppo, Ana Paula Del Bortolo Ruenis, Gilson Cesar Nobre Franco
Publikováno v:
International journal of clinical pharmacology and therapeutics. 43(8)
Objective: To compare the bioavailability of clarithromycin 500 mg tablets (Merck S.A Industrias Quimicas, Sao Paulo, SP, Brazil, used as test formulation) and Klaricid® (Abbott LaboratOrios do Brasil Ltda, Sao Paulo, SP, Brazil, used as reference f
Autor:
Marta M. D. C. Vila, Yoko Oshima-Franco, Miriéle Cristina Ferraz, Arturo San Feliciano, José Carlos Cogo, Luiz Madaleno Franco, Pilar Puebla, Márcio Galdino dos Santos
Publikováno v:
Toxicon. 60:196-197
Autor:
Sinvaldo Baglie, A.P. Del Bortolo Ruenis, Francisco Carlos Groppo, Luiz Madaleno Franco, E. Abib, Pedro Luiz Rosalen, R.H. Lopes Motta, G.C. Nobre Franco, Ronilson Agnaldo Moreno, R. P. Simoes
Publikováno v:
Scopus-Elsevier
OBJECTIVE To assess the pharmacokinetics of clarithromycin (CLR) and its effects on oral and nasal microbiota in healthy volunteers in an open, randomized, two-period crossover design. METHODS A single 500 mg oral dose of CLR (Group 1: Merck; Group 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17f84675856d5ce318f4ab76b3eaeee2
http://www.scopus.com/inward/record.url?eid=2-s2.0-62749167068&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-62749167068&partnerID=MN8TOARS